The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and European Confederation of Medical
Mycology (ECMM) wanted to tackle a challenge that no major scientific society had tried: providing a guideline on the
diagnosis and management of rare and emerging fungal diseases.